GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma

Clinical trial NCT02499003 · COMPLETED

Trial details

NCT number: NCT02499003
Sponsor: Johannes Gutenberg University Mainz
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2015-08-14
Primary completion: 2019-01-02
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.